Liver Cancer

Hepatocellular carcinoma (HCC) is a common tumor type arising from several distinct etiologies. It is usually diagnosed late and is difficult to treat. This volume presents an overview of selected aspects of HCC pathogenesis, and research aimed at developing diagnostic biomarkers. It points to a num...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
פורמט: Online
שפה:אנגלית
יצא לאור: IntechOpen 2023
נושאים:
גישה מקוונת:ONIX_20230905_9781803564142_159
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
_version_ 1869517346519908352
collection Directory of Open Access Books
description Hepatocellular carcinoma (HCC) is a common tumor type arising from several distinct etiologies. It is usually diagnosed late and is difficult to treat. This volume presents an overview of selected aspects of HCC pathogenesis, and research aimed at developing diagnostic biomarkers. It points to a number of putative therapeutic targets, including signal transduction pathways, metabolic and epigenetic alterations in tumor cells, the tumor microenvironment, the gut microbiome, and functions of immune effector cells. Given the multi-step nature of most cancers, including HCC, future drug development will most likely require combination therapies that will simultaneously target multiple steps in hepatocarcinogenesis.
format Online
id doab-20.500.12854ir-113358
institution Directory of Open Access Books
language eng
publishDate 2023
publishDateRange 2023
publishDateSort 2023
publisher IntechOpen
publisherStr IntechOpen
record_format ojs
spelling doab-20.500.12854ir-1133582024-03-31T22:45:52Z Liver Cancer Feitelson, Mark Arzumanyan, Alla hepatocellular carcinoma liver cirrhosis inflammation biomarkers immunotherapy gene expression thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Hepatocellular carcinoma (HCC) is a common tumor type arising from several distinct etiologies. It is usually diagnosed late and is difficult to treat. This volume presents an overview of selected aspects of HCC pathogenesis, and research aimed at developing diagnostic biomarkers. It points to a number of putative therapeutic targets, including signal transduction pathways, metabolic and epigenetic alterations in tumor cells, the tumor microenvironment, the gut microbiome, and functions of immune effector cells. Given the multi-step nature of most cancers, including HCC, future drug development will most likely require combination therapies that will simultaneously target multiple steps in hepatocarcinogenesis. 2023-09-05T16:00:18Z 2023-09-05T16:00:18Z 2023 book ONIX_20230905_9781803564142_159 9781803564142 9781803564135 9781803564159 https://directory.doabooks.org/handle/20.500.12854/113358 eng image/jpeg n/a https://www.intechopen.com/books/11596 https://mts.intechopen.com/storage/books/11596/authors_book/authors_book.pdf IntechOpen IntechOpen 10.5772/intechopen.100845 10.5772/intechopen.100845 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 9781803564142 9781803564135 9781803564159 IntechOpen 146 open access
spellingShingle hepatocellular carcinoma
liver cirrhosis
inflammation
biomarkers
immunotherapy
gene expression
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
Liver Cancer
title Liver Cancer
title_full Liver Cancer
title_fullStr Liver Cancer
title_full_unstemmed Liver Cancer
title_short Liver Cancer
title_sort liver cancer
topic hepatocellular carcinoma
liver cirrhosis
inflammation
biomarkers
immunotherapy
gene expression
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
topic_facet hepatocellular carcinoma
liver cirrhosis
inflammation
biomarkers
immunotherapy
gene expression
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
url ONIX_20230905_9781803564142_159